Taysha Gene Therapies Inc at Chardan Genetic Medicines Conference (Virtual) Transcript
Hello, and it's now my pleasure to introduce our next fireside chat guest. From Taysha Gene Therapies, we have RA Session, President, Chief Executive Officer and Founder; Kamran Alam, CFO; and Dr. Suyash Prasad, CMO and Head of R&D at Taysha Gene Therapies. (Operator Instructions) Thank you again to our guests for joining us today.
So to start off, RA, maybe you could provide us with a couple minutes of introductory comments on Taysha, including any recent business developments like from today for example, and on this upcoming milestone.
Sure, I'm happy to do so, and Geulah, thanks for having us. We're always excited to interact with you and the Chardan team. You guys have been great supporters of the story from the early beginning, and so we really appreciate the support.
So really Taysha is a company that is built on a foundational collaboration with UT Southwestern, which we expanded on earlier today with the announcement of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |